Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patients with Plexiform Neurofibromas
Annual rept. 1 Apr 2013-30 Jun 2013
INDIANA UNIV INDIANAPOLIS
Pagination or Media Count:
The goal of this Pilot Study is to trail multiple techniques for determining the response of NF1 patients with plexiform neurofibromas to Gleevec registered therapy for use in subsequent clinical trials. The impact of this proposal is having a better way to measurequantify the response of plexiform neurofibromas in NF1 patients to treatment.
- Medicine and Medical Research